antineoplastic monoclonal antibody

A mononclonal antibody used to treat malignant neoplasm(s)

Specific

alemtuzumab (Campath-1H, Lemtrada) amivantamab (Rybrevant) atezolizumab (Tecentriq) avelumab (Bavencio) belantamab mafodotin-blmf (Blenrep) bevacizumab (Avastin, Altuzan) blinatumomab (Blincyto) camrelizumab cemiplimab (Libtayo) cetuximab (Erbitux) daratumumab (Darzalex) dinutuximab (Unituxin) dostarlimab-gxly (JEMPERLI) durvalumab (Imfinzi) elotuzumab (Empliciti) elranatamab-bcmm (Elrexfio) enfortumab vedotin (Padcev) epcoritamab-bysb (Epkinly) flotetuzumab gemtuzumab ozogamicin (Mylotarg) glofitamab-gxbm (Columvi) ibritumomab tiuxetan inotuzumab ozogamicin (Besponsa) ipilimumab (Yervoy) isatuximab isatuximab-irfc (Sarclisa) ivonescimab lazertinib (Lazcluze) loncastuximab tesirine-lpyl (Zynlonta) margetuximab mirvetuximab soravtansine-gynx (Elahere) mogamulizumab-kpkc (Poteligeo) mosunetuzumab-axgb (Lunsumio) moxetumomab pasudotox (Lumoxiti) naxitamab-gqgk (Danyelza) necitumumab (Portrazza) nivolumab (Opdivo) obinutuzumab (Gazyva) ofatumumab (Arzerra, Kesimpta) olaratumab (Lartruvo) panitumumab (Vectibix) pembrolizumab (Keytruda) pertuzumab (Perjeta) ranibizumab (Lucentis, Byooviz) retifanlimab (Zynyz) rituximab (Rituxan, Mabthera, Truxima, Ruxience, Riabni) sacituzumab govitecan-hziy (Trodelvy) sugemalimab talquetamab tarlatamab (AMG 757) teclistamab-cqyv (Tecvayli) tislelizumab toripalimab-tpzi (Loqtorzi) tositumomab (Bexxar) tovorafenib trastuzumab (Herceptin, Herzuma, CT-P6) tremelimumab (Imjudo) zolbetuximab-clzb

General

antineoplastic agent (chemotherapeutic agent) pharmaceutical monoclonal antibody